Stock Events

Merck KGAA 

€159.6
253
-€2.9-1.78% Wednesday 14:10

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
-
P/E Ratio
-
Dividend Yield
1.38%
Dividend
2.2

Upcoming

14
NOV
Earnings
 
29
APR 25
Dividend Ex
Estimated
 
2
MAY 25
Dividend Payment
Estimated
 
29
APR 26
Dividend Ex
Estimated
 
2
MAY 26
Dividend Payment
Estimated
 

Dividends

1.38%Dividend Yield
May 24
€2.2
May 23
€2.2
Apr 22
€1.85
Apr 21
€1.4
Jun 20
€1.3
10Y Growth
8.76%
5Y Growth
11.97%
3Y Growth
16.26%
1Y Growth
N/A

Earnings

14NovExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
1.84
2.01
2.19
2.36
Expected EPS
2.3204017049960783
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1MRK.MI. It's not an investment recommendation.
Alphabet
78395
GOOGL
Apple
68177
AAPL
Microsoft
63621
MSFT
Amazon
59331
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap164.39B
Pfizer competes in various pharmaceutical areas with Merck KGAA, including oncology and vaccines.
Johnson & Johnson
JNJ
Mkt Cap399.26B
Johnson & Johnson competes through its pharmaceutical division, Janssen, in areas like immunology and oncology.
Novartis
NVS
Mkt Cap244.75B
Novartis competes in multiple therapeutic areas including neuroscience and oncology, similar to Merck KGAA.
Roche
RHHBY
Mkt Cap272.83B
Roche competes in oncology, neuroscience, and infectious diseases, directly challenging Merck KGAA's product lines.
GSK
GSK
Mkt Cap89.55B
GlaxoSmithKline competes in pharmaceuticals and vaccines, including HIV and respiratory diseases, overlapping with Merck KGAA.
Abbvie
ABBV
Mkt Cap346.75B
AbbVie competes in areas like immunology and oncology, directly against Merck KGAA's interests.
Merck
MRK
Mkt Cap300.25B
Merck & Co. (known as MSD outside the US and Canada) competes directly in pharmaceuticals, especially in oncology.
Bristol-Myers Squibb
BMY
Mkt Cap101.27B
Bristol Myers Squibb competes in cardiovascular, oncology, and immunoscience, similar to Merck KGAA's portfolio.
Sanofi
SNY
Mkt Cap141.43B
Sanofi competes in diabetes, oncology, and rare diseases, areas where Merck KGAA is also active.
AMGEN
AMGN
Mkt Cap179.38B
Amgen competes in areas such as oncology and cardiovascular disease, overlapping with Merck KGAA's therapeutic areas.

About

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
Show more...
CEO
Stefan Oschmann
Employees
62176
Country
DE
ISIN
DE0006599905

Listings

US
MKGAF
F
DE
MRK.F
VI
AT
MRCK.VI
SW
CH
MER.SW